Prematurez y bajo peso al nacer: casi 50% de los neonatos de menos de 1.000 g que reciben AP desarrollan colestasia, lo que ocurre en slo 7% de los que pesan ms de 1.500 g
Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021
Importantly, FDA-approved labeling for weight management products in this classincluding Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide)does include specific warnings about suicidal behavior and ideation in the Warnings and Precautions section
MTT assay was used to assess cytotoxicity
May improve heart health Several GLP-1 medications appear to improve heart health and reduce the risk for cardiovascular events
How to protect your bones during weight loss Experts expect GLP-1 use to grow